Iron oxide nanoparticle-mediated radiation delivery for glioblastoma treatment

Peter A. Chiarelli, Richard A. Revia, Zachary R. Stephen, Kui Wang, Forrest M. Kievit, Jordan Sandhu, Meenakshi Upreti, Seokhwan Chung, Richard G. Ellenbogen, Miqin Zhang

Research output: Contribution to journalArticlepeer-review

Abstract

Radiotherapy is a mainstay adjunctive therapy for glioblastoma (GBM). Despite the outcome improvement achieved with radiation, GBM prognosis remains dismal. Here we introduce a tumor-targeted iron oxide nanoparticle (NP) that intensifies the energy transfer of conventional photon radiotherapy on a selective cellular basis. Several NPs were formulated with systematic architectural variation to study and optimize reactive oxygen species (ROS) production. Selected from this screening stage, a biocompatible tumor-targeted NP was tested in vitro using two models of GBM, and then in vivo, using an orthotopic human primary GBM xenograft mouse model. Animals that received intravenous NP before irradiation demonstrated a 3-fold reduction in tumor growth and a 2-fold increase in survival. Cellular damage was investigated using in vivo magnetic resonance spectroscopy, which demonstrated increased therapeutic cytotoxicity specific to the tumor mass. Our work presents a viable therapeutic strategy to improve radiation therapy for GBM.

Original languageEnglish (US)
Pages (from-to)66-78
Number of pages13
JournalMaterials Today
Volume56
DOIs
StatePublished - Jun 2022
Externally publishedYes

Keywords

  • Enhanced radiation therapy
  • Glioblastoma treatment
  • Iron oxide nanoparticles
  • Magnetic resonance spectroscopy
  • Radiosensitization

ASJC Scopus subject areas

  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanics of Materials
  • Mechanical Engineering

Fingerprint

Dive into the research topics of 'Iron oxide nanoparticle-mediated radiation delivery for glioblastoma treatment'. Together they form a unique fingerprint.

Cite this